That class, called GLP-1 agonists, is Novo Nordisks biggest seller, accounting for 57% of its total sales in 2022
This small, butterfly-shaped gland in your neck acts as the master controller of your metabolism
Disclosures Jos Luis Grriz has served as consultant to Boehringer Ingelheim, Mundipharma, AstraZeneca, and Novo Nordisk and has received speaker honoraria from Boehringer Ingelheim, Mundipharma, AstraZeneca, Novo Nordisk, Novartis, and Eli Lilly and Company
Self-prescribing supplements without medical guidance may delay appropriate investigation of potentially significant digestive problems
Mar 19, 2025 S3.E6: My Life on GLP-1: More Poop Talk and Constipation Management Tackle the dreaded constipation side effect of GLP-1 medications with our comprehensive relief guide
Key Questions Answered in this Report How many companies are currently engaged in this market